Home › Funds › Beau Ventures, LLc › CVS
Beau Ventures, LLc position in CVS
CVS HEALTH CORP · Consumer Staples
Beau Ventures, LLc reported holding 325,432 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$27.9M, representing 2.63% of its reported portfolio and ranking #6 among its reported holdings. Beau Ventures, LLc has disclosed CVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Beau Ventures, LLc's CVS position evolved
Beau Ventures, LLc first disclosed a stake in CVS in Q4 2025 at 325,037 shares (US$25.8M). The position peaked in Q2 2026 at 325,301 shares, worth US$33.7M. Across 4 filings, Beau Ventures, LLc held the position steady without any share-count change. The most recent filing (Q3 2026) shows 325,432 shares valued at US$27.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 325.04K | $25.79M | New |
| Q1 2026 | 325.18K | $23.35M | Hold |
| Q2 2026 | 325.30K | $33.65M | Hold |
| Q3 2026 | 325.43K | $27.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Beau Ventures, LLc
FAQ
How long has Beau Ventures, LLc held CVS?
Beau Ventures, LLc has disclosed CVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Beau Ventures, LLc's current position in CVS?
As of Q3 2026, Beau Ventures, LLc holds 325.43K shares of CVS (CVS HEALTH CORP), valued at $27.89M, representing 2.63% of its reported portfolio and ranking #6.
Has Beau Ventures, LLc been buying or selling CVS?
In the latest 13F filing (Q3 2026), Beau Ventures, LLc held unchanged its position in CVS. The position peaked in Q2 2026 at 325.30K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.